These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 311959)

  • 21. [DDAVP: alternative therapy in moderate pathology of Factor VIII/von Willebrand].
    Vicente V; Alberca I; Moraleda JM; López Borrasca A
    Sangre (Barc); 1983; 28(4):531-2. PubMed ID: 6606856
    [No Abstract]   [Full Text] [Related]  

  • 22. Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin.
    de la Fuente B; Kasper CK; Rickles FR; Hoyer LW
    Ann Intern Med; 1985 Jul; 103(1):6-14. PubMed ID: 3923887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beneficial effect of D.D.A.V.P. on bleeding-time in von Willebrand's disease.
    Menon C; Berry EW; Ockelford P
    Lancet; 1978 Sep; 2(8092 Pt 1):743-4. PubMed ID: 80674
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of hemophilia A and von Willebrand's disease with 1-deamino-8-D-arginine vasopressin (DDAVP). Hemophilia and DDAVP].
    Ingerslev J; Christiansen SE; Kristensen T; Wallevik K; Bernvil SS
    Ugeskr Laeger; 1985 Nov; 147(45):3592-4. PubMed ID: 3907076
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical application of DDVP on hemophiliacs].
    Kobayashi I; Takahashi H
    Nihon Ketsueki Gakkai Zasshi; 1982 Sep; 45(5):975-86. PubMed ID: 6818810
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of blood coagulation disorders with the vasopressin derivative DDAVP (Minirin)].
    Köhler M; Hellstern P; Vief B; Wenzel E
    ZFA (Stuttgart); 1981 May; 57(15):1132-5. PubMed ID: 6973250
    [No Abstract]   [Full Text] [Related]  

  • 27. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal administration of desmopressin acetate (DDAVP) to hemophiliacs.
    Dewald DL; Briggs B; Smith RE
    Thromb Res; 1980 Jun; 18(5):617-22. PubMed ID: 6774441
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical experience with deamino-8-D-AGR-Vasopressin (DDAVP) in patients with Factor VIII deficiency.
    Sweeney JD; Crosby P; McCann SR; Temperley IJ
    Ir J Med Sci; 1981 Aug; 150(8):236-9. PubMed ID: 6974718
    [No Abstract]   [Full Text] [Related]  

  • 30. DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium.
    Sakariassen KS; Cattaneo M; vd Berg A; Ruggeri ZM; Mannucci PM; Sixma JJ
    Blood; 1984 Jul; 64(1):229-36. PubMed ID: 6428488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DDAVP in acquired von Willebrand syndrome associated with multiple myeloma.
    Takahashi H; Nagayama R; Tanabe Y; Satoh K; Hanano M; Mito M; Shibata A
    Am J Hematol; 1986 Aug; 22(4):421-9. PubMed ID: 3088986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
    Fukui H; Takase T
    Rinsho Ketsueki; 1985 Jul; 26(7):1069-79. PubMed ID: 3932720
    [No Abstract]   [Full Text] [Related]  

  • 33. Adenotonsillectomy in children with von Willebrand's disease: how and when. A case report with review of the literature.
    Berlucchi M; Tomenzoli D; Nicolai P; Lusk RP
    Int J Pediatr Otorhinolaryngol; 2002 Sep; 65(3):253-6. PubMed ID: 12242142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Patients with moderate von Willebrand's disease. Response to Willebrand factor with DDAVP].
    Alphonse O
    Soins; 1989; (526-527):3-4. PubMed ID: 2814607
    [No Abstract]   [Full Text] [Related]  

  • 35. [Moderate von Willebrand's disease type I: use of desmopressin].
    Soufarapis H; Lefrançois C; Derlon A
    Ann Fr Anesth Reanim; 1990; 9(5):466-7. PubMed ID: 2240704
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathy.
    Castaman G; Rodeghiero F; Di Bona E; Ruggeri M
    Blut; 1989 Apr; 58(4):211-3. PubMed ID: 2784985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1-Desamino-8-arginine-vasopressin corrects the hemostatic defects in type 2B von Willebrand's disease.
    McKeown LP; Connaghan G; Wilson O; Hansmann K; Merryman P; Gralnick HR
    Am J Hematol; 1996 Feb; 51(2):158-63. PubMed ID: 8579058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the discrepant post-DDAVP increase of FVIII:C and von Willebrand factor in some patients with severe von Willebrand's disease.
    Casonato A; Pontara E; Bertomoro A; Zucchetto A; Zerbinati A; Girolami A
    Br J Haematol; 1995 Oct; 91(2):512-3. PubMed ID: 8547104
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
    Holmberg L; Nilsson IM; Borge L; Gunnarsson M; Sjörin E
    N Engl J Med; 1983 Oct; 309(14):816-21. PubMed ID: 6412139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perioperative management of patients with von Willebrand's disease.
    Cameron CB; Kobrinsky N
    Can J Anaesth; 1990 Apr; 37(3):341-7. PubMed ID: 2182206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.